Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective study
Open Access
- 5 January 2016
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 172 (6) , 966-977
Abstract
Summary: Children with sickle cell disease (SCD) have a significant vascular morbidity, especially cerebral macrovasculopathy (CV), detectable by transcranial Doppler. This study aimed to identify risk factors for CV using longitudinal biological and clinical data in a SCD newborn cohort followed at the Robert Debre Reference centre (n = 375 SS/Sβ0). Median follow‐up was 6·8 years (2677 patient‐years). Among the 59 children presenting with CV, seven had a stroke. Overall, the incidence of CV was 2·20/100 patient‐years [95% confidence interval (95%CI): 1·64–2·76] and the incidence of stroke was 0·26/100 patient‐years (95%CI: 0·07–0·46). The cumulative risk of CV by age 14 years was 26·0% (95%CI: 20·0‐33·3%). Risk factors for CV were assessed by a Cox model encompassing linear multivariate modelling of longitudinal quantitative variables. Years per upper‐airway obstruction [Hazard ratio (HR) = 1·47; 95%CI: 1·05–2·06] or bronchial obstruction (HR = 1·76; 95% CI: 1·49–2·08) and reticulocyte count (HR = 1·82 per 50 × 109/l increase; 95%CI: 1·10–3·01) were independent risk factors whereas fetal haemoglobin level (HR = 0·68 per 5% increase; 95%CI: 0·48–0·96) was protective. Alpha‐thalassaemia was not protective in multivariate analysis (ancillary analysis n = 209). Specific treatment for upper or lower‐airway obstruction and indirect targeting of fetal haemoglobin and reticulocyte count by hydroxycarbamide could potentially reduce the risk of CV.Keywords
This publication has 65 references indexed in Scilit:
- Magnetic resonance angiography‐defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose‐6‐phosphate dehydrogenase mutation in children with sickle cell anaemiaBritish Journal of Haematology, 2012
- Genetic predictors for stroke in children with sickle cell anemiaBlood, 2011
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- Improved survival of children and adolescents with sickle cell diseaseBlood, 2010
- Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemiaBritish Journal of Haematology, 2009
- Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemiaHaematologica, 2009
- Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive PainPLOS ONE, 2008
- Increased Cerebral Blood Flow Velocity in Children With Mild Sleep-Disordered Breathing: A Possible Association With Abnormal Neuropsychological FunctionPediatrics, 2006
- Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final resultsBlood, 2006
- Stroke in a cohort of patients with homozygous sickle cell diseaseThe Journal of Pediatrics, 1992